Merck (XSWX:MRK) Total Debt per Share: CHF17.45 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:MRK Merck & Co Inc XSWX:MRK
71 GF Score
Price CHF122.12
GF Value CHF95.97
! 7 Warning Signs
View Full Analysis

What is Merck Total Debt per Share?

Merck XSWX:MRK +1.09% 71 Total Debt per Share is CHF17.45 as of Jun. 2026. GuruFocus rates XSWX:MRK with a GF Score™ of 71/100 and a GF Value™ of CHF95.97. The stock has 7 warning signs investors should review.

CHF17.45 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Merck's Total Debt Per Share for the quarter that ended in Jun. 2026 was CHF17.45.

Merck Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Merck's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck Total Debt per Share Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.06 11.27 11.98 13.09 15.89

Merck Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.50 13.24 15.89 15.66 17.45
XSWX:MRK
71GF Score
Merck & Co Inc XSWX:MRK
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck Total Debt per Share Calculation

Merck's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(37,255+2,063)/2,475
=15.89

Merck's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(40,829+2,258)/2,469
=17.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of CHF17.45 mean?
Merck (XSWX:MRK) has a Total Debt per Share of CHF17.45 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Merck and its competitors.
Is Merck's Total Debt per Share too high?
Merck's current Total Debt per Share is CHF17.45. Overall, Merck has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Merck's Total Debt per Share compare to AMGN and ABBV?
Merck's Total Debt per Share of CHF17.45 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Merck and its competitors. Merck's current Total Debt per Share is CHF17.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Merck (XSWX:MRK) has a current Total Debt per Share of CHF17.45. The stock's GF Value™ is CHF95.97, compared to a current price of CHF122.12 — trading 27.2% above its estimated fair value. The current Total Debt per Share is CHF17.45. Merck's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Merck (XSWX:MRK), the current Total Debt per Share is CHF17.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (XSWX:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of CHF122.12 is trading 27.2% above its estimated GF Value™ of CHF95.97.

Key valuation signals for XSWX:MRK:

  • Total Debt per Share: CHF17.45
  • GF Value™: CHF95.97 vs. price of CHF122.12 (27.2% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the XSWX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
71GF Score

Get the complete analysis for XSWX:MRK

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF122.12
Price
CHF95.97
GF Value